Q: Two questions - Could I have your take on SGML recent earnings please, and (2) HHL has diverged vigorously from its past consistent performance, presumably on the Trump policy on health care, appointees etc. I assume other sector participants will likewise take a hit but would appreciate your take on the matter. The issues affecting the sector appear to relate to policy, not politics.
5i Research Answer:
SGML EPS was -23c on revenue of $20.9M, missing consensus by a wide margin. Concentrate sold was...